West Pharmaceutical
WST
WST
778 hedge funds and large institutions have $24.4B invested in West Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 258 increasing their positions, 306 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
5% less capital invested
Capital invested by funds: $25.7B → $24.4B (-$1.29B)
16% less repeat investments, than reductions
Existing positions increased: 258 | Existing positions reduced: 306
56% less funds holding in top 10
Funds holding in top 10: 9 → 4 (-5)
Holders
778
Holding in Top 10
4
Calls
$80.7M
Puts
$78.2M
Top Buyers
| 1 | +$457M | |
| 2 | +$130M | |
| 3 | +$99M | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$64.5M |
| 5 |
FPP
Findlay Park Partners
London,
United Kingdom
|
+$63.5M |
Top Sellers
| 1 | -$219M | |
| 2 | -$184M | |
| 3 | -$134M | |
| 4 |
GCM
Gladstone Capital Management
London,
United Kingdom
|
-$80.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$63.3M |